Old Web
English
Sign In
Acemap
>
authorDetail
>
Jan Delabie
Jan Delabie
University Health Network
Medicine
Immunology
Cancer research
Diffuse large B-cell lymphoma
Obinutuzumab
3
Papers
10
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Obinutuzumab Plus Gemcitabine, Dexamethasone and Cisplatin (O-GDP) As Salvage Chemotherapy Prior to Autologous Stem Cell Transplant in Aggressive B Cell Lymphoma
2018
Blood
Michael D Jain
Anca Prica
Ryan D. Morin
Vishal Kukreti
Robert Kridel
Rob C. Laister
Li Meng
Christopher Rushton
Miguel Alcaide
Rashmi S. Goswami
Jan Delabie
J. Weiss
Tony Panzarella
Michael Crump
David W. Scott
John Kuruvilla
Show All
Source
Cite
Save
Citations (0)
Alemtuzumab Added to CHOP for Treatment of Peripheral T-Cell Lymphoma (PTCL) in Previously Untreated Young and Elderly Patients: Pooled Analysis of the International ACT-1/2 Phase III Trials
2018
Blood
Bettina Altmann
Gerald Wulf
Lorenz Truemper
Francesco d’Amore
Thomas Relander
Helle Toldbod
Jan Delabie
Andreas Rosenwald
Marita Ziepert
Markus Loeffler
Show All
Source
Cite
Save
Citations (9)
Young High Risk Patients with MYC/BCL2 Double Hit Lymphoma, BCL2+ and/or Germinal Centre B-Cell like Diffuse Large B-Cell Lymphoma Benefit from Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis: Analysis of Data from the Nordic Lymphoma Group CRY-04 and Chic Trials
2018
Blood
Sirpa Leppä
Judit Jørgensen
Leo Meriranta
Klaus Beiske
Jan Delabie
Elisabeth Ralfkiaer
Signe Spetalen
Marja-Liisa Karjalainen-Lindsberg
Harald Holte
Show All
Source
Cite
Save
Citations (1)
1